Biosimilars for treating follicular lymphoma – update on clinical trials
Why do we need biosimilars?
Biosimilars - the question of trials and approval
The use of trastuzumab and biosimilars in the treatment of breast cancer
Biosimilars: Making biological agents availble worldwide
Won Seog Kim